---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-008824"
form_type: "8-K"
ticker: "QCLS"
cik: "0001321834"
company_name: "Q/C TECHNOLOGIES, INC."
filed_at: "2024-03-05T23:59:59+00:00"
generated_at: "2026-06-05T03:27:41.211003+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# MyMD Pharmaceuticals regains Nasdaq minimum bid price compliance after reverse stock split

## Summary
- Received notice from Nasdaq on March 4, 2024 that it has regained compliance with Listing Rule 5550(a)(2).
- Deficiency flagged Oct 11, 2023 after shares failed to maintain $1.00 bid for 30 consecutive days.
- Conducted a 1-for-30 reverse stock split on Feb 14, 2024; split-adjusted trading began Feb 15.
- Minimum bid price of $1.00 maintained for 10 consecutive business days, requirement met on March 1, 2024.

## SEC filing metadata
- accession: 0001493152-24-008824
- form_type: 8-K
- ticker: QCLS
- cik: 0001321834
- company_name: Q/C TECHNOLOGIES, INC.
- filed_at: 2024-03-05T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1321834/000149315224008824/0001493152-24-008824-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1321834/000149315224008824/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-008824
- JSON: https://secwatch.observer/filing/0001493152-24-008824.json
- Plain text: https://secwatch.observer/filing/0001493152-24-008824.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.